Craft

Societal CDMO

Stock Price

$0.4

2024-02-02

Market Capitalization

$41.6 M

2024-02-02

Revenue

$90.2 M

FY, 2022

Societal CDMO Summary

Company Summary

Overview
Recro Gainesville (also known as Recro Pharma) is a clinical-stage specialty pharmaceutical company developing non-opioid therapeutics for the treatment of pain. The сompany is engaged in developing products for hospitals and ambulatory care settings that are developing non-opioid products for the treatment of serious acute pain. The сompany's lead product candidate is an injectable form of meloxicam.
Type
Public
Status
Active
Founded
2006
HQ
Gainesville, GA, US | view all locations
Website
https://www.societalcdmo.com/
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Key People

  • Wayne B. Weisman, Chairman of the Board

    • David Smithwick

      David Smithwick, Senior Vice President and Site Head

      • Ryan D. Lake

        Ryan D. Lake, CFO

        • Shazib Jamil

          Shazib Jamil, Senior Vice President and Site Head

          Operating MetricsView all

          Patents Issued

          13
          73.5%

          FY, 2016

          LocationsView all

          3 locations detected

          • Gainesville, GA HQ

            United States

            1300 Gould Dr

          • Gainesville, GA

            United States

            988 Chestnut St SE

          • San Diego, CA

            United States

            6828 Nancy Ridge Dr #100

          Societal CDMO Financials

          Summary Financials

          Revenue (Q3, 2023)
          $23.6M
          Gross profit (Q3, 2023)
          $3.7M
          Net income (Q3, 2023)
          ($4.6M)
          Cash (Q3, 2023)
          $8.2M
          EBIT (Q3, 2023)
          ($1.8M)
          Enterprise value
          $70.8M

          Footer menu